- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about TEVA
Recent news which mentions TEVA
5 of the Safest Stocks Billionaire Money Managers Bought Ahead of Wall Street's Historic Volatility
April 13, 2025
From Motley Fool
These Are My 3 Worst-Performing Stocks So Far in 2025 -- and the One I'm Buying More of Now
March 28, 2025
From Motley Fool
Billionaire Stanley Druckenmiller Jettisoned Shares of Palantir and Nvidia, and Is Piling Into 3 High-Profile Turnaround Stocks
March 24, 2025
From Motley Fool
From Motley Fool
Is SoundHound AI Stock a Buy Now?
March 05, 2025
From Motley Fool
Sanofi/Teva Unveil New Detailed Data For Duvakitug Study Supporting Overall Efficacy For Common Inflammatory Bowel Disease
February 24, 2025
From Benzinga
Billionaire Stanley Druckenmiller Dumped Duquesne's Entire Stake in Broadcom and Bought One of Wall Street's Hottest Drug Stocks Hand Over Fist
February 20, 2025
From Motley Fool
Billionaire Investor Stanley Druckenmiller Dumps Broadcom, Bets Big On Tesla, Amazon And Other Big Tech Stocks In Q4
February 18, 2025
From Benzinga
WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
February 16, 2025
From Benzinga
This Stock Is Already Up by 55% in 2025: Is It Too Late to Buy?
February 16, 2025
From Motley Fool
Axsome Therapeutics Resolves Generic Patent Litigation With Teva Over Depression Drug, Analyst Maintains Axsome As 'Top Pick For 2025'
February 10, 2025
From Benzinga
Neurocrine Biosciences Reports Mixed Q4
February 07, 2025
From Motley Fool
NVIDIA, Teva Pharmaceutical And UPS Are Among Top Large Cap Losers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio?
February 02, 2025
From Benzinga
What Analysts Are Saying About Teva Pharmaceutical Indus Stock
January 30, 2025
Tickers
TEVA
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 29, 2025
From Benzinga
Tickers
TEVA
From Motley Fool
Crude Oil Down 1.5%; Teva Pharmaceutical Shares Plummet
January 29, 2025
From Benzinga
Stocks Tick Down Ahead Of Fed Meeting, Nvidia Jitters Resume, Trump Media Rallies: What's Driving Markets Wednesday?
January 29, 2025
From Benzinga
Nasdaq Down Over 100 Points; Corning Posts Upbeat Earnings
January 29, 2025
From Benzinga
Teva Pharmaceutical Stock Falls On Q4 Earnings: What's Going On?
January 29, 2025
From Benzinga
Manhattan Associates, LendingClub And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
January 29, 2025
From Benzinga
Earnings Scheduled For January 29, 2025
January 29, 2025
From Benzinga
Teva's Duvakitug Set To Shake Up IBD Treatment, Analyst Highlights Competitive Data
January 28, 2025
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 27, 2025
From Benzinga
From Benzinga
Peering Into Teva Pharmaceutical Indus's Recent Short Interest
January 27, 2025
Tickers
TEVA
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.